NEW YORK and ANN ARBOR Mich. Aug. 22 2016 PRNewswire &160;Lycera Corp. a privately held biopharmaceutical company developing breakthrough immune modulatory medicines announced today the initiation of a Phase 2 clinical trial of the Company's lead clini...
↧